🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.00
-1.95 (-1.43%)
At close: Nov 18, 2026, 4:00 PM EST
133.76
-0.24 (-0.18%)
Pre-market: Nov 19, 2026, 8:22 AM EST

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,0489,2074,1003,7663,3491,424
Market Cap Growth
0.09%124.55%8.88%12.44%135.22%-53.20%
Enterprise Value
6,9599,1013,9653,5353,2161,359
Last Close Price
134.00182.6484.6179.5977.1337.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.1514.4210.6313.9266.94-
PB Ratio
66.82104.2871.9219.7230.5791.10
P/TBV Ratio
122.28257.66-29.9784.6191.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.0414.2510.2813.0664.28-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.132.473.380.980.863.18
Net Debt / Equity Ratio
-0.85-1.19-2.15-1.05-0.97-2.35
Net Debt / EBITDA Ratio
0.590.650.501.140.620.30
Net Debt / FCF Ratio
1.091.120.951.370.910.34
Asset Turnover
1.161.010.670.590.24-
Inventory Turnover
1.762.172.162.68--
Quick Ratio
1.291.451.993.462.473.75
Current Ratio
1.421.562.113.632.543.75
Return on Equity (ROE)
-175.59%-252.12%-231.63%-159.21%-298.97%-201.51%
Return on Assets (ROA)
-13.65%-16.81%-27.28%-24.86%-52.30%-56.91%
Return on Capital Employed (ROCE)
-51.50%-54.40%-74.60%-40.70%-74.70%-192.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.28%-1.99%-7.00%-6.35%-5.59%-9.16%
FCF Yield
-1.17%-1.02%-3.14%-3.87%-3.50%-7.62%
Buyback Yield / Dilution
-4.67%-3.82%-5.48%-11.73%-8.07%-1.11%
SEC Filings: 10-K · 10-Q